From: Changes in initiation of adjuvant endocrine therapy for breast cancer after state health reform
Breast cancer patients aged 20–64 years | 0.050*** |
[0.024, 0.075] | |
N | 20,551 |
Breast cancer patients aged 20–49 years | 0.071*** |
[0.029, 0.113] | |
N | 7960 |
Breast cancer patients aged 50–64 years | 0.036** |
[0.004, 0.068] | |
N | 12,591 |